Logger Script
HOME > PRACTICES > Intellectual Property > International Dispute Management Print

As legal disputes escalate to multi-front wars in different countries, clients need attorneys having a worldwide perspective on intellectual property matters (“IP”).  Yulchon’s international dispute management team has that requisite knowledge and experience.  From litigations to arbitrations, the members of this team have experience in virtually every venue throughout the world that is popular for IP matters.  More importantly, the members of the team have significant in-house experience and seek to understand each client’s business goals to provide a successful resolution of each matter.
 

Major Practice Areas
 

  • International IP Litigation Management, Coordination, and Strategy (working with local foreign counsel in the following procedures)
  • US District Court litigations
  • US International Trade Commission investigations
  • European Patent Office (oppositions)
  • German District Court litigations and invalidity proceedings
  • Japanese District Court litigations and invalidity proceedings
  • US Re-examinations and post-grant review proceedings
  • International Arbitrations (IP and technology), which are administered by various arbitral institutions, such as the following
  • International Chamber of Commerce (ICC)
  • London Court of International Arbitration (LICA)
  • American Arbitration Association (AAA)
  • Korean Commercial Arbitration Board (KCAB)
  • Licensing (IP and technology)
  • Negotiations
  • Drafting contracts

  • Coordinating IP litigation issues with outside counsel in multiple countries for a major Korean electronics company
  • Advising Korean pharmaceutical company on US district court litigation
  • Advising a Korean chemical fiber company on US district court litigation
  • Successfully advised a Korean software company on licensing negotiations with a foreign company
  • Successfully conducted due diligence on US patent assets for a Korean telecommunications carrier.
  • Successfully advised a Korean pharmaceutical company in a license agreement to transfer technology to a multi-national pharmaceutical company

Contact Professionals

※ Please download Acrobat Reader to view, print and collaborate on PDF files. Get ADOBE READER